12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Pritelivir: Phase II started

AiCuris began the double-blind, crossover, U.S. Phase II AIC316-01-II-02 trial to compare 100 mg oral AIC316 once daily vs. 500 mg oral valacyclovir once daily...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >